Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Molecular Biology,Molecular Medicine
Reference221 articles.
1. Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease;Abassi;Am. J. Physiol. Lung Cell Mol. Physiol.,2021
2. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19);Agrati;Cell Death Differ.,2020
3. Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase;Al-Shamlan;Respir. Res.,2019
4. Can COVID-19 induce an autoimmune disease associated with long-lasting symptoms and delayed complications?;Amiral;Ann. Clin. Immunol. Microbiol.,2020
5. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease;Anguiano;Nephrol. Dial. Transplant.,2015
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors;European Journal of Medicinal Chemistry;2024-01
2. Molecular Mechanisms of Endothelialitis in SARS-CoV-2 Infection: Evidence for VE-Cadherin Cleavage by ACE2;International Journal of Molecular Sciences;2023-08-07
3. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases;Inflammation Research;2023-08
4. Circulating ACE2 level and zinc/albumin ratio as potential biomarkers for a precision medicine approach to COVID-19;Advances in Biological Regulation;2023-08
5. ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAS dysregulation in severe cases;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3